Stories
& Articles

At So Brave, we believe that stories have the power to heal, to connect, and to change the way the world sees young women with breast cancer.

Real voices of
Our community

Personal Stories
First-hand accounts of understanding a risk of breast cancer, diagnosis, treatment, and life beyond cancer.

Blog Features
Honest conversations about dating after diagnosis, parenting through treatment, body image, fertility, going flat after surgery, and more.

We don’t sugar-coat the hard parts, and we don’t shy away from the truth. Because being seen starts with being honest and every story shared helps another woman feel less alone.

Zoladex 10.8mg PBAC update

The Pharmaceutical Benefits Advisory Committee (PBAC) recently reviewed AstraZeneca’s submission to expand the listing for the ZOLADEX® (goserelin) three monthly (10.8mg) implant for the management of oestrogen-receptor (ER) positive early...

Zoladex 3.6mg update from AstraZeneca

So Brave received the following updated revised advice from AstraZeneca this morning about the supply of Zoladex 3.6mg: The AstraZeneca media release accompanying today’s announcement is available via this link...

Positive Ovarian Suppression medication recommendation from PBAC

So Brave received the following updated advice from  PBAC this morning: PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE (PBAC) MEETING OUTCOMES ITEMS CONSIDERED OUT OF SESSION BETWEEN ORDINARY MEETINGS (JULY 2026 – SEPTEMBER...

Zoladex Continuity Program – UPDATE 16 July

So Brave received the following updated advice from AstraZeneca this afternoon: ONGOING ACCESS TO ZOLADEX® (goserelin) MONTHLY (3.6mg) IMPLANT IN AUSTRALIA PBS News: Update on access to goserelin 3.6 mg...

So Brave x Cancer Australia Partnership

Amongst so many amazing things happening in our community at the moment, from incredible volunteers representing young women at the Cancer Nurses Society Of Australia (CNSA) conference in Perth last...

So Brave Founder and Managing Director – Rachelle Panitz – ABC News Radio – Zoladex delisting

What’s the latest on the delisting of Zoladex 3.6mg? Listen to our recent ABC News Radio interview about the situation and what’s been happening since the announcement on 1 May....

Zoladex 3.6mg delisting update

So Brave is aware of the cancellation notice for Zoladex Goserelin 3.6mg (as Acetate) Implant Syringe, as of November 1, 2026. Please note that the Zoladex Gosrelin 10.8mg (used in...

Pregnancy and Postpartum Associated Cancers (PAC) Project

Improving diagnosis, care, and support for women diagnosed during pregnancy or postpartum The Pregnancy and Postpartum Associated Cancers (PAC) Project is being delivered nationally under the Cancer Priority Setting Partnership (CPSP) — a new...

National Day of Awareness

Uniting Australia to recognise young women’s breast cancer On 1 September 2025, So Brave launched the first National Day of Awareness for Young Women’s Breast Cancer  a moment to recognise, remember, and...

bravespace

Creating a safe and supportive community for young women with cancer bravespace was created as a central, safe, and inclusive online community for young women diagnosed with cancer to access mental...

Resensation Mastectomies

Bringing sensation-preserving reconstruction to Australia In 2021, So Brave held several patient and clinician webinars in collaboration with US-based specialists Dr Minas Chrysopoulo and Dr Anne Peled to introduce and promote sensation-preserving and resensating...

Blood Test for Breast Cancer Detection

Empowering early detection through research and innovation So Brave supports cutting-edge research and innovation that can lead to earlier, easier, and more accurate detection of breast cancer, especially for young...